Showing results (121-130 of 2,104) with videos related to

Sort By:
Pageof 211
CNS Drugs|May 9, 2014
Changes in gait variability with anti-dementia drugs: a systematic review and meta-analysisO Beauchet, C P Launay, G Allali, et al.
CNS Drugs|March 13, 2017
Monoclonal Antibodies for Relapsing Multiple Sclerosis: A Review of Recently Marketed and Late-Stage AgentsMorten Blinkenberg, Per Soelberg Sørensen
CNS Drugs|April 10, 2014
PPAR-γ agonism as a modulator of mood: proof-of-concept for pioglitazone in bipolar depressionDavid E Kemp, Martha Schinagle, Keming Gao, et al.
CNS Drugs|April 12, 2014
Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosisRenaud A Du Pasquier, Daniel D Pinschewer, Doron Merkler
CNS Drugs|February 15, 2014
Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targetsAnthony O Ahmed, Ishrat A Bhat
CNS Drugs|March 2, 2017
Effect of Fingolimod on Brain Volume Loss in Patients with Multiple SclerosisNicola De Stefano, Diego G Silva, Michael H Barnett
CNS Drugs|February 17, 2017
Binge Drinking: Current Diagnostic and Therapeutic IssuesBenjamin Rolland, Mickaël Naassila
CNS Drugs|February 26, 2017
Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and AtomoxetineLeonie Hennissen, Mireille J Bakker, Tobias Banaschewski, et al.
CNS Drugs|December 21, 2016
Effect on Cognition of Estroprogestins Combined with Interferon Beta in Multiple Sclerosis: Analysis of Secondary Outcomes from a Randomised Controlled TrialLaura De Giglio, Fabiana Marinelli, Valeria T Barletta, et al.
CNS Drugs|November 24, 2016
Impact of Drug Manipulation on Seizure Freedom in Adults with Uncontrolled Epilepsy: A Prospective Controlled Study in Rural ChinaXiaoting Hao, Ziyi Chen, Bo Yan, et al.
Pageof 211